Research Institute of Life and Health Sciences, Higher School of Medicine, Kokshetau University named after Sh. Ualikhanov, Kokshetau, Kazakhstan.
Central Asian Institute for Medical Research, Astana, Kazakhstan.
Asian Pac J Cancer Prev. 2024 May 1;25(5):1763-1775. doi: 10.31557/APJCP.2024.25.5.1763.
The aim is to study the trends of liver cancer (LC) incidence in the regional context in Kazakhstan.
The retrospective study was done using descriptive and analytical methods of oncoepidemiology. The extensive, crude and age-specific incidence rates are determined according to the generally accepted methodology used in sanitary statistics. The data were used to calculate the average percentage change (APС) using the Joinpoint regression analysis to determine the trend over the study period.
Between 2005 and 2019, 13,510 cases of LC were documented, comprising 59.3% males and 40.7% females. Most diagnoses were seen in age groups 55-59 years (13.3%) to 75-79 years (11.7%). LC patients' average age increased from 63.6 to 64.5 years. Incidence rates per 100,000 peaked at ages 65-69 years (35.1±1.0) and 70-74 years (43.3±1.0). LC incidence notably rose in the 70-74 years age group (APC=+0.89), contrasting with declining trends in younger age groups. Regional incidence variations revealed diverse patterns, mostly demonstrating unimodal increases, and some regions displaying bimodal growth. The age-standardized incidence rate was 5.7±0.1 per 100,000, declining from 2005 to 2012 (APC: -3.93), then rising until 2019 (APC: +1.13). Gender-specific standardized rates showed varied trends. Analyses of standardized indicators indicated declining trends in most regions but increased values in specific areas. Thematic maps classified incidence rates based on standardized indicators: low (up to 5.22), average (5.22 to 7.11), high (above 7.11 per 100,000 for the entire population).
The study on liver cancer in Kazakhstan reveals marked gender and age differences. The standardized incidence rate among men was twofold greater than that among women. A distinct rise in cases was noted among individuals aged 70-74 years. Regional variations in incidence were evident. These findings emphasize the necessity for focused research to comprehend the causes behind these differences, enabling customized interventions for Kazakhstan's population.
研究哈萨克斯坦地区肝癌(LC)发病率的趋势。
本研究采用描述性和分析性肿瘤流行病学方法进行回顾性研究。根据卫生统计中普遍采用的方法,确定广泛的、粗的和年龄特异性的发病率。使用 Joinpoint 回归分析计算平均百分比变化(APC),以确定研究期间的趋势。
2005 年至 2019 年间,共记录了 13510 例 LC 病例,其中男性占 59.3%,女性占 40.7%。大多数诊断见于 55-59 岁(13.3%)至 75-79 岁(11.7%)年龄组。LC 患者的平均年龄从 63.6 岁增加到 64.5 岁。每 100000 人发病率最高的年龄为 65-69 岁(35.1±1.0)和 70-74 岁(43.3±1.0)。70-74 岁年龄组的 LC 发病率显著上升(APC=+0.89),而年轻年龄组的发病率呈下降趋势。区域发病率的变化呈现出不同的模式,主要表现为单峰增长,一些地区呈双峰增长。年龄标准化发病率为每 100000 人 5.7±0.1,从 2005 年到 2012 年(APC:-3.93)下降,然后到 2019 年(APC:+1.13)上升。性别标准化率显示出不同的趋势。对标准化指标的分析表明,大多数地区的趋势是下降的,但在一些特定地区有所上升。根据标准化指标的专题地图将发病率分类:低(低至 5.22)、中(5.22 至 7.11)、高(全人群为 7.11 以上每 100000 人)。
本研究表明,哈萨克斯坦的肝癌存在明显的性别和年龄差异。男性的标准化发病率是女性的两倍。70-74 岁人群中肝癌发病率明显上升。发病率的区域差异明显。这些发现强调了需要进行有针对性的研究,以了解这些差异背后的原因,从而为哈萨克斯坦人口制定有针对性的干预措施。